Description

Synthetic tripeptide (Glu-Asp-Arg) from the Khavinson “bioregulator” research family, alongside Epitalon. Proposed (not confirmed) to act by entering the cell nucleus and directly modulating gene expression in neurons, rather than binding a surface receptor. Studied for neuroprotection under oxidative stress, antioxidant activity, and circadian/melatonin regulation; research is almost entirely from Russian academic groups, with essentially no controlled human trial data, and not FDA-approved.